人民卫生出版社系列期刊
ISSN 2096-2738 CN 11-9370/R

中国科技核心期刊(中国科技论文统计源期刊)
2020《中国学术期刊影响因子年报》统计源期刊
美国化学文摘社(CAS)数据库收录期刊
日本科学技术振兴机构(JST)数据库收录期刊

新发传染病电子杂志 ›› 2023, Vol. 8 ›› Issue (1): 87-92.doi: 10.19871/j.cnki.xfcrbzz.2023.01.018

• 指南与共识 • 上一篇    下一篇

2022年WHO全球结核病报告:全球与中国关键数据分析

宋敏1, 陆普选2, 方伟军1, 韩远远1, 梁瑞云1   

  1. 1.广州市胸科医院放射科,广东 广州 510095;
    2.深圳市慢性病防治中心医学影像科,广东 深圳 518020
  • 收稿日期:2022-04-19 出版日期:2023-02-28 发布日期:2023-03-30
  • 通讯作者: 方伟军,Email:fangweijun9@sohu.com

The global tuberculosis report 2022: key data analysis for China and the global world

Song Min1, LU Puxuan2, Fang Weijun1, Han Yuanyuan1, Liang Ruiyun1   

  1. 1. Department of Radiology, Guangzhou Chest Hospital, Guangdong Guangzhou 510095, China;
    2. Department of Imaging, Center for Chronic Disease Prevention of Shenzhen, Guangdong Shenzhen 518020, China
  • Received:2022-04-19 Online:2023-02-28 Published:2023-03-30

摘要: 结核病是仅次于新型冠状病毒感染(COVID-19)的第二大传染性疾病杀手,也是全球第十三大死亡原因。《2022年全球结核病报告》(以下简称2022年报告)显示:2021年,全世界估计新增1060万结核病患者,其中600万人是成年男性,340万人是成年女性,120万人是儿童。HIV感染者占总数的6.7%。新诊断的患有结核病并向各国政府报告的病例数从2020年的580万恢复到2021年的640万,仍有约420万未被诊断或未被报告。结核病发病率上升,死亡病例数有所增加。2021年,由结核病引起的死亡病例数估计是由HIV感染引起的死亡病例数的两倍多。2021年新增45万例利福平耐药结核病(RR-TB)患者,明显高于2020年,然而耐药结核病的治疗覆盖率及治疗成功率依然较低。2022年报告提示COVID-19大流行在全球结核病防治工作中的影响仍在继续。2022年报告呼吁多部门加倍努力,增加对基本结核病服务和研究的资助,减轻和扭转COVID-19大流行对结核病防治服务的负面影响,以实现终结结核病的目标和拯救生命。

关键词: 世界卫生组织, 结核病, 报告, 新型冠状病毒感染, 艾滋病

Abstract: Tuberculosis is the second largest killer of infectious diseases after coronavirus disease 2019(COVID-19), and it also is the 13th largest cause of death in the world. The global tuberculosis(TB) report 2022 shows that, an estimated 10.6 million people worldwide will be infected with tuberculosis in 2021, of which 6 million will be men, 3.4 million women and 1.2 million children. HIV-positive people accounted for 6.7 percent of the total. The reported number of people newly diagnosed with TB had recovered from 5.8 million in 2020 to 6.4 million in 2021, but there were still about 4.2 million people who had not been diagnosed or reported. The incidence rate of tuberculosis had risen with an increased number of TB deaths. In 2021, the estimated number of deaths caused by TB was more than double the number caused by HIV/AIDS. 450 000 patients have been newly diagnosed with rifampicin-resistant tuberculosis (RR-TB) in 2021, which number was significantly higher than that in 2020. However, the treatment coverage and treatment success rate for drug-resistant tuberculosis(DR-TB) was still low. The report suggests that the impact of the COVID-19 epidemic on global tuberculosis prevention and control still continued. The report calls on multiple departments to redouble their efforts to increase funding for basic tuberculosis services and research, to reduce and reverse the negative impact of COVID-19 on tuberculosis prevention and control services, so as to achieve the goal of ending tuberculosis and save lives.

Key words: World Health Organization, Tuberculosis, Report, Coronavirus disease 2019, Acquired immunodeficiency syndrome

中图分类号: